HealthEquity (NASDAQ:HQY) Shares Down 3.3%

HealthEquity, Inc. (NASDAQ:HQYGet Free Report) dropped 3.3% during trading on Wednesday . The company traded as low as $79.82 and last traded at $80.03. Approximately 244,076 shares traded hands during mid-day trading, a decline of 60% from the average daily volume of 604,468 shares. The stock had previously closed at $82.79.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on HQY. Bank of America boosted their price target on HealthEquity from $93.00 to $97.00 and gave the company a “buy” rating in a report on Wednesday, March 20th. BTIG Research upped their target price on HealthEquity from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, March 20th. Raymond James increased their price objective on HealthEquity from $90.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, December 13th. Wells Fargo & Company upped their target price on HealthEquity from $89.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 6th. Finally, KeyCorp upped their target price on HealthEquity from $85.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, March 22nd. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $95.73.

Check Out Our Latest Stock Analysis on HealthEquity

HealthEquity Trading Down 3.5 %

The company has a 50 day moving average of $80.37 and a 200-day moving average of $73.62. The company has a debt-to-equity ratio of 0.43, a quick ratio of 4.76 and a current ratio of 4.76. The stock has a market cap of $6.86 billion, a price-to-earnings ratio of 126.25, a price-to-earnings-growth ratio of 1.37 and a beta of 0.53.

Insider Buying and Selling

In other HealthEquity news, EVP Delano Ladd sold 2,558 shares of the stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $82.59, for a total value of $211,265.22. Following the sale, the executive vice president now owns 47,438 shares of the company’s stock, valued at approximately $3,917,904.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other HealthEquity news, EVP Delano Ladd sold 2,558 shares of the stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $82.59, for a total value of $211,265.22. Following the sale, the executive vice president now owns 47,438 shares of the company’s stock, valued at approximately $3,917,904.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jon Kessler sold 33,765 shares of the stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the sale, the chief executive officer now directly owns 126,635 shares in the company, valued at approximately $10,106,739.35. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 73,908 shares of company stock valued at $5,863,915. Corporate insiders own 2.70% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Hedge funds and other institutional investors have recently made changes to their positions in the business. Janney Montgomery Scott LLC grew its stake in HealthEquity by 4.7% during the 4th quarter. Janney Montgomery Scott LLC now owns 3,115 shares of the company’s stock worth $207,000 after buying an additional 140 shares during the last quarter. Xponance Inc. raised its holdings in HealthEquity by 1.2% during the fourth quarter. Xponance Inc. now owns 12,269 shares of the company’s stock worth $813,000 after purchasing an additional 147 shares during the last quarter. O Shaughnessy Asset Management LLC raised its holdings in HealthEquity by 3.3% during the second quarter. O Shaughnessy Asset Management LLC now owns 5,060 shares of the company’s stock worth $319,000 after purchasing an additional 160 shares during the last quarter. Fifth Third Bancorp raised its holdings in HealthEquity by 36.5% during the third quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock worth $44,000 after purchasing an additional 161 shares during the last quarter. Finally, Metropolitan Life Insurance Co NY raised its holdings in shares of HealthEquity by 3.6% in the fourth quarter. Metropolitan Life Insurance Co NY now owns 5,190 shares of the company’s stock worth $320,000 after acquiring an additional 179 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

About HealthEquity

(Get Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Stories

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.